Enzo Health, the AI-driven platform for home health and post-acute care, has announced a $20 million Series A funding round led by N47, bringing the company’s total funding to $26 million. Existing investors Gradient, Tandem Ventures, and Rigby Watts also participated.
The funding positions Enzo to meet surging demand for in-home care as more than 10,000 Americans turn 65 every day. Launched in 2024, Enzo Health has grown revenue by more than 40 times in twelve months and is now used by organizations that support more than 500,000 patients annually. The company plans to use a portion of the Series A proceeds to expand its AI-driven platform into the skilled nursing and hospice sectors.
Enzo’s platform automates and connects home health and post-acute care providers’ front office, clinical operations, and back office functions in a single system, handling the entire workflow from referral to reimbursement while minimizing regulatory risk. Three core modules drive the platform’s value: Enzo Intake, which analyzes referrals instantly and converts faxes, emails, and PDFs into structured data while checking eligibility in seconds; Enzo Scribe, which delivers AI-assisted clinical documentation in real time during patient visits so clinicians finish charting before leaving the home; and Enzo QA, which continuously reviews charts for clinical and regulatory accuracy before issues affect reimbursement or compliance. The platform addresses conditions driving severe strain on the home health sector, including clinician turnover that hovers near 80% within the first 100 days, driven in large part by documentation burden.
N47 partner Vivian Cheng described Enzo as redefining how home health organizations operate by removing the administrative burden that has long defined the industry, enabling clinicians and agencies to serve more patients. Gradient partner Andrew Brackin, whose firm led Enzo’s seed round, characterized the home health category as needing a platform rather than another disconnected AI point solution and described Enzo as moving exceptionally fast toward a clear and ambitious vision. Co-founder and CEO Zach Newman noted that agencies delivering home care are being squeezed from every direction, with compliance and operational requirements growing while legacy software was never designed to handle them.
The aging of the Baby Boomer generation is creating structural demand for home health that will persist for decades. According to the U.S. Department of Health and Human Services, seven out of ten Americans will require long-term care at some point in their lifetime, and jobs in the home health sector are expected to grow by roughly 17% from 2024 to 2034 according to the Bureau of Labor Statistics.
KEY QUOTES:
“Home health is one of the fastest-growing segments in healthcare due to the rapidly expanding 65+ demographic. But the agencies delivering that care are being squeezed from every direction. Their compliance and operational requirements keep growing, while the solutions they’re using were never built to handle these demands. The result is burned-out clinicians, unsustainable turnover, and patients who can’t get the care they need. Enzo fixes that.”
Zach Newman, Co-Founder and CEO, Enzo Health
“Enzo is redefining how home health organizations operate, removing the administrative burden that has long defined the industry and enabling clinicians and agencies to serve more patients.”
Vivian Cheng, Partner, N47
